Quantcast

Latest Parkinson's disease Stories

Genetic Makeup Determines Parkinson's Risk From Pesticide Use
2014-02-05 09:34:22

Rebekah Eliason for redOrbit.com – Your Universe Online In the past, studies have shown that pesticides can cause an increased risk for the development of Parkinson’s disease. Recently, UCLA researchers have discovered that amount of risk varies with a person’s individual genetic makeup. People with a specific genetic variant and are living in extreme pesticide-exposed areas have an increased likelihood of developing the disease by two- to six-fold. Previously, the UCLA team found...

2014-02-04 23:03:41

In-demand research study “Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management” worked out by GBI Research has been recently published by Market Publishers Ltd. According to the report, by 2019-end, the Parkinson’s disease therapeutics market value is poised to decline to close to USD 2.9 billion. London, UK (PRWEB) February 04, 2014 At present, the Parkinson’s disease (PD) therapeutics market is led by symptomatic...

2014-02-04 12:27:52

VALLEY VIEW, Ohio, Feb. 4, 2014 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson's therapy in response to motor symptoms. The allowed claims include a portable system for measuring, quantifying, and treating Parkinson's disease, based on a calculated severity of tremor, bradykinesia, rigidity, or dyskinesia. The claims also...

2014-01-29 13:07:05

A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease. These findings, which were made using an animal model of the disease, demonstrate that a single therapy could simultaneously repair the multiple types of neurological damage caused by Parkinson's, providing an overall benefit that has not been achieved in other approaches. "One of the central...

2014-01-29 12:28:20

Alliance Leverages Independent Nonprofit Strengths to Enrich Programs for Parkinson's Community NEW YORK, Jan. 29, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce its support of the Alliance of Independent Regional Parkinson Organizations (AIRPO), a consortium recently formed with the shared goals of finding a cure for Parkinson's and supporting those who live with the disease. AIRPO encourages collaboration, leverages...

2014-01-29 12:27:59

NEW YORK, Jan. 29, 2014 /PRNewswire-USNewswire/ -- Research projects from three biopharmaceutical companies in the United States comprise the 2013 second half (2H 2013) of The Michael J. Fox Foundation for Parkinson's Research (MJFF) Partnering Program. Among the most promising in the MJFF portfolio, Partnering Program participants' research projects are presented directly to industry groups who may wish to invest in further development of the project. By connecting industry leaders...

2014-01-28 08:27:30

Young Artist, Despite Dystonia, Uses His Artistic Skills To Raise Money For Dystonia Research LAS VEGAS, Jan. 28, 2014 /PRNewswire/ -- Imagine a potentially debilitating neuromuscular disease that is relatively unknown, yet affects a half-million Americans of various ages, and, despite ongoing research, so far has no known cure. In addition, treatments are currently limited and carry significant side effects and risk. Would this qualify as a disease worthy of public awareness and...

Stalling Symptoms Of Parkinson's Disease Using Long-term Spinal Cord Stimulation
2014-01-24 11:11:58

Duke University Medical Center Researchers at Duke Medicine have shown that continuing spinal cord stimulation appears to produce improvements in symptoms of Parkinson's disease, and may protect critical neurons from injury or deterioration. The study, performed in rats, is published online Jan. 23, 2014, in the journal Scientific Reports. It builds on earlier findings from the Duke team that stimulating the spinal cord with electrical signals temporarily eased symptoms of the...

2014-01-16 16:23:33

DUBLIN, January 16, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/c3wr96/neuroprotection) has announced the addition of a new report "Neuroprotection - Drugs, Markets and Companies" [http://www.researchandmarkets.com/research/c3wr96/neuroprotection ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the role of neuroprotection in acute disorders such as stroke and...

2014-01-08 23:04:51

Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, and Adamas Pharmaceuticals Inc., today announced an agreement for Phase 3 clinical trials manufacturing of ADS-5102 (amantadine HCl) extended release capsules, an investigational treatment being developed for Levodopa-Induced Dyskinesia (LID) in patients with Parkinson’s disease. Somerset, NJ (PRWEB) January 08, 2014 Catalent Pharma...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related